INHIBIKASE THERAPEUTICS INC
IKT·45719W205·US·Common Stock·Healthcare - Biotechnology-13D/G
IKT (INHIBIKASE THERAPEUTICS INC) is held by 61 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($10.6M), Blackstone Inc. ($10M), VANGUARD CAPITAL MANAGEMENT LLC ($7.5M). Net institutional sentiment: Bullish.
61
Holders
Avg rating(14 Elite)
$51.8M
Total Value
82% (65)
Fund Consensus
50 buying - 11 selling
Who's Trading
ActivistCOCommodore Capital LP9.9%May 15, 2026
ActivistPAPerceptive Advisors LLC8.9%May 15, 2026
ActivistADADAR1 Capital Management, LLC9.9%May 15, 2026
ActivistTETrails Edge Capital Partners, LP6.1%May 15, 2026
ActivistFAFairmount Funds Management LLC9.9%Feb 17, 2026
ActivistNANantahala Capital Management, LLC5.7%Feb 13, 2026
ActivistSLSands Capital Life Sciences Pulse Fund II, L.P.10.8%Feb 13, 2026
InsiderSLSands Capital Life Sciences Pulse Fund II, L.P.Buy $3.0MNov 21, 2025
13F: Insider & Congress:
Showing 1-20 of 65
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer